The Sahajanand Medical Technologies IPO will open for public subscription on October 15, 2026, giving investors an opportunity to participate in the public listing of the medical device manufacturer.
The company has fixed the price band at Rs 327 to Rs 344 per share for its Rs 475.48 crore issue.
The IPO will remain open until October 19, 2026. Investors planning to apply should review the minimum lot size, subscription categories, allotment schedule and the structure of the offer before making an investment decision.
Sahajanand Medical Technologies IPO Price Band and Lot Size
The company has set a price band of Rs 327 to Rs 344 per equity share.
Retail investors can apply for a minimum of 43 shares, which means an application at the upper end of the price band will require Rs 14,792, excluding applicable charges.
Investors applying for additional shares must do so in multiples of the minimum lot, according to the issue terms.
The final amount required will depend on the bid price and the number of shares selected.
IPO Is Entirely an Offer for Sale
The Rs 475.48 crore public issue comprises an offer for sale (OFS) of approximately 1.38 crore shares by existing shareholders.
There is no fresh issue component in this offering.
This means the proceeds from the sale will go to the shareholders selling their stakes rather than to Sahajanand Medical Technologies itself.
An OFS allows existing investors to sell shares to public investors while the company enters the stock market.
The selling shareholders include the promoters and existing investors. Investors should read the company’s offer documents to understand the shareholding structure and the details of the shares being offered.
Sahajanand Medical Technologies IPO Allotment and Listing Dates
The IPO is scheduled to follow this timetable:
The subscription window will run from October 15 to October 19, 2026.
The basis of allotment is expected on October 21, while refunds and credit of shares to eligible investors’ demat accounts are scheduled for October 22.
The shares are scheduled to list on October 23, 2026. These dates are subject to the final issue schedule and any official changes.
The issue has reserved 50% of the net offer for qualified institutional buyers, 35% for retail individual investors and 15% for non-institutional investors.
The final allotment will depend on the subscription received in the respective investor categories.
What Does Sahajanand Medical Technologies Do?
Sahajanand Medical Technologies operates in the medical devices sector, focusing on products used in vascular and structural heart interventions.
Its portfolio includes coronary balloons, coronary stents, transcatheter aortic valve implantation (TAVI) products, occluders and peripheral drug-coated balloons.
The company’s products are used in specialised medical procedures, including interventions involving blood vessels and structural heart conditions.
Its presence in this segment gives investors exposure to the medical technology industry, although the company’s future performance will depend on business operations, competition and other financial factors.
What Investors Should Check Before Applying
Before applying for the Sahajanand Medical Technologies IPO, investors should review the red herring prospectus, financial statements, valuation, business risks and the objectives of the existing shareholders selling their stakes.
Since the issue is entirely an OFS, the company will not receive fresh capital from the IPO.
Investors should also remember that listing gains are not guaranteed and that share prices can rise or fall after listing.
A careful review of the issue documents and personal risk tolerance can help investors make an informed decision rather than relying only on the IPO size or the price band.
